Category: Biotech

1 2 10 / 11 POSTS
InSitu Biologics is an emerging biotech company focusing on development of AnestaGel™, a long-lasting and long-acting non-opiate painkiller. The sustained release drug AnestaGel is expected to be used in post-operative surgical procedures. Anesta ...
Precision Biosciences is a gene editing company that was able to raise $110 million in June. They are using what is called a homing endonuclease which can potentially recognize very specific DNA sequences and replace them with new DNA sequences. ...
Allogene Therapeutics, Grail, Brii BioSciences, Moderna Therapeutics, Precision BioSciences, Kaleido Biosciences, Constellation Pharmaceuticals, Stealth BioTherapeutics, PACT Pharma, Beam Therapeutics. Healthcare was 15% of total deal activity i ...
Dr. Todd Malan is an internationally recognized Stem Cell Pioneer and leading expert in the field of regenerative medicine. He was the first US physician to perform a stem cell breast augmentation in 2009. He is an innovator and leading expert in ...
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Financial UpdateOn July 23, 2018, MediciNova, Inc. (NASDAQ:MNOV) filed form 10-Q with financial results for the second quarter of 2018. As expected, the company did not report any rev ...
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Financial UpdateOn July 23, 2018, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced financial results for the second quarter of 2018 and provided a business update. As expect ...
John Vandermosten Senior Biotechnology Analyst Zacks Small Cap Research http://scr.zacks.com John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small cap biotechn ...
Dr. Michael Lazar California HIFU Medical Director - HIFU Prostate Services http://californiahifu.com/ HIFU (High-Intensity Focused Ultrasound) is a minimally-invasive surgical procedure recently introduced to the U.S, and only available in a few ...
Regular CEO Money contributor John Vandermosten from Zacks Small-Cap Research guests hosts this interview: Douglas Fambrough President and CEO Dicerna Pharmaceuticals - NASDAQ:DRNA http://dicerna.com Today we are going to speak with Doug Fam ...
James F. Oliviero President and CEO - Checkpoint Therapeutics - NASDAQ: CKPT http://www.checkpointtx.com/ Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is a clinical-stage, immuno-oncology biopharmaceutical company focused on the development of a ...
1 2 10 / 11 POSTS